Overview
Location
United States, California, Los Angeles
Mentions in press and media 13
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Feb 17, 2017 | NEA Leads $41M Round For Rhythm | Rhythm, a biopharmaceutical company developing peptide therapeutics for rare genetic deficiencies that result in life-threatening metabolic disorders, today announced the completion of a $41 million mezzanine round of financing with existin... |
| Feb 16, 2017 | Rhythm Closes $41M Mezzanine Financing | Rhythm, a Boston, MA-based biopharmaceutical company developing peptide therapeutics for rare genetic deficiencies that result in life-threatening metabolic disorders, completed a $41m mezzanine round of financing. Backers included existing... |
| Feb 16, 2017 | Rhythm Announces Completion of $41 Million Mezzanine Financing | |
| Feb 16, 2017 | Rhythm Completes $41 Million Mezzanine Financing | Rhythm, a biopharmaceutical company developing peptide therapeutics for rare genetic deficiencies that result in life-threatening metabolic disorders, today announced the completion of a $41 million mezzanine round of financing with existin... |
| Aug 17, 2015 | Rhythm Subsidiary Raises $40 Million in Oversubscribed Financing | |
| Aug 13, 2015 | Rhythm Completes $40M Series A Financing | Rhythm, a Boston, Massachusetts-based biopharmaceutical company developing peptide therapeutics that address unmet needs in gastrointestinal diseases and obesity, completed a $40m Series A financing. New investors OrbiMed, Deerfield Managem... |
| Nov 27, 2012 | Rhythm Closes Additional $8M in Series B Financing | Rhythm, a Boston, MA-based biotechnology company, has closed on an additional $8m in Series B financing. Pfizer Venture Investments, the venture capital arm of Pfizer, has joined existing investors MPM Capital, New Enterprise Associates, Th... |
| Jun 13, 2012 | Rhythm Raises $25M in Series B Financing | Rhythm, a Boston, Massachusetts-based biotechnology company developing peptide therapeutics that address needs in metabolic diseases, has raised $25m in Series B financing. Backers include all existing investors MPM Capital (MPM), New Enter... |
| May 18, 2012 | Rapid Rhythm Secures £50K | Rapid Rhythm Ltd, a Manchester, UK-based company that has invented a device to help diagnose Atrial Fibrillation (AF), has secured a £50k investment from The North West Fund for Biomedical. The company intends to use the capital to develop ... |
Show more
Reviews 0
FAQ about RHYTHM
What has the press written about RHYTHM?
Parsers VC has collected 13 articles mentioning RHYTHM, among them “NEA Leads $41M Round For Rhythm” (Feb 17, 2017) and “Rhythm Closes $41M Mezzanine Financing” (Feb 16, 2017).
Is RHYTHM still active?
Yes, RHYTHM is active; its latest activity on Parsers VC dates from Jun 26, 2018.